Nonmesh surgery for stress urinary incontinence has higher risk of reoperation at 10 years: Study
UK: Women with stress urinary incontinence (SUI) treated with retropubic colposuspension versus mesh sling insertion or autologous sling procedures experience a higher risk of reoperation at 10 years after surgery, shows a recent study. The study appears in the American Journal of Obstetrics and Gynecology. Safety and effectiveness of surgical treatments for stress urinary incontinence...
UK: Women with stress urinary incontinence (SUI) treated with retropubic colposuspension versus mesh sling insertion or autologous sling procedures experience a higher risk of reoperation at 10 years after surgery, shows a recent study. The study appears in the American Journal of Obstetrics and Gynecology.
Safety and effectiveness of surgical treatments for stress urinary incontinence have been always debatable. Controversy about the use of synthetic mesh sling insertion resulted in an increase use of retropubic colposuspension and autologous sling procedures. However, there is a need for comparative evidence on the long-term outcomes from these procedures.
Considering the above, Patrick Muller, London School of Hygiene & Tropical Medicine, London, United Kingdom, and colleagues aimed to compare the risk of reoperation at 10 years after operation between women treated for stress urinary incontinence with retropubic colposuspension, mesh sling insertion, and autologous sling procedures.
For this purpose, the researchers used records of admissions to National Health Service hospitals to identify women who had first-time stress incontinence surgery between 2006 and 2013 in England. They then assessed the first incidence of following outcomes: further stress incontinence surgery, surgery for a complication (either mesh removal, prolapse repair, or incisional hernia repair), and any reoperation (either further stress incontinence surgery, mesh removal, prolapse repair, or incisional hernia repair).
They calculated the cumulative incidence of each of these outcomes up to 10 years after surgery with death being considered as a competing event. The reoperation hazard ratios was estimated for the different initial surgery types with adjustments for patient characteristics and concurrent prolapse surgery or hysterectomy.
The analysis included 2262 women treated with retropubic colposuspension, 92,524 treated with mesh sling insertion, and 1234 treated with autologous sling.
Key findings of the study include:
· The cumulative incidence of any first reoperation at 10 years was 21.3% after retropubic colposuspension, 10.9% after mesh sling insertion, and 12.0% after autologous sling procedures.
· The women who had a retropubic colposuspension were significantly more likely to have a reoperation than women who had an autologous sling (adjusted hazard ratio for any reoperation: 1.79; for further stress incontinence surgery: 1.64; for surgery for complications: 1.89), whereas the women who had mesh slings had a similar hazard (for any reoperation: 0.90; for further stress incontinence surgery: 0.75; for surgery for complications: 1.11).
· A sensitivity analysis excluding the women who had concurrent prolapse surgery or hysterectomy produced similar results.
To conclude, women treated with retropubic colposuspension had nearly double the risk of any reoperation in the first 10 years after SUI surgery, versus women treated with a mesh sling insertion or an autologous sling procedure. The researchers therefore suggests that women considering surgical treatment for SUI should be provided with robust information on its long-term effectiveness and the risk of adverse events.
"However, these three procedures may have different severity of the conditions leading to reoperation, implying the need for long-term patient-reported outcome data to give a complete picture of the risks and benefits associated with each procedure," the authors wrote.
Muller P, Gurol-Urganci I, van der Meulen J, et al. Risk of reoperation 10 years after surgical treatment for stress urinary incontinence: a national population-based cohort study. Am J Obstet Gynecol 2021;225:645.e1-14.
Medha, MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at firstname.lastname@example.org. Contact no. 011-43720751